≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)

Endpoint Browser

C3_LIP_ORAL_PHARYNX_NAS_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C14
  • Hospital discharge: ICD-9 — 149
  • Hospital discharge: ICD-8 — 149
  • Cause of death: ICD-10 — C14
  • Cause of death: ICD-9 — 149
  • Cause of death: ICD-8 — 149
  • Cancer registry: Topography ICD-O-3 — C14
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

85

4. Check minimum number of events

None

85

5. Include endpoints

None

85

6. Filter based on genotype QC (FinnGen only)

85

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 85 19 66
Unadjusted period prevalence (%) 0.02 0.01 0.03
Median age at first event (years) 67.29 65.01 67.95

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
25
20
17.29
26.69
1.6
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
21
32
8.39
13.92
2.9
1.3
g/l
0.2
0.2
0.68
21
24
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
55
235
4.80
11.34
5.4
3.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
44
172
4.23
9.93
3.3
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
39
147
4.05
9.12
4.2
4.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
8
18.86
8.87
1.3
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
28
87
4.31
8.45
7.7
2.8
mmol/l
0.8
0.8
3.28
28
81
(3013650) Neutrophils [#/volume] in Blood by Automated count
56
299
3.56
7.28
13.9
6.2
e9/l
4.3
4.2
0.10
51
251
(3044640) Blood type and Crossmatch panel - Blood
38
164
3.38
6.91
3.7
2.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
48
239
3.32
6.89
6.4
8.9
inr
1.4
1.4
0.04
12
66
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
31
123
3.39
6.38
3.4
2.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
23
75
3.83
6.35
2.4
1.9
—
—
—
0
0
(3002256) Pathology report gross observation
16
43
4.35
5.68
1.6
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
23
84
3.38
5.30
2.0
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
37
184
2.79
4.95
5.2
5.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
8
9.40
3.85
1.1
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
10
25
4.40
3.82
10.4
7.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
44
267
2.34
3.63
6.1
5.5
e9/l
0.7
0.6
0.74
39
225
(3006315) Basophils [#/volume] in Blood
44
267
2.34
3.63
7.0
5.5
e9/l
0.0
0.0
0.45
39
229
(3018010) Neutrophils/100 leukocytes in Blood
42
251
2.33
3.57
6.5
5.6
%
64.4
57.5
2.55
37
227
(3002030) Lymphocytes/100 leukocytes in Blood
42
252
2.32
3.53
5.5
5.8
%
22.8
27.2
1.48
37
224
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
28
3.91
3.30
1.2
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
18
78
2.66
3.00
1.7
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
6
8.75
2.78
1.0
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
16
4.66
2.53
2.7
4.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
20
100
2.31
2.46
2.0
2.3
mmol/l
2.5
2.4
0.95
14
78
(3003396) Base excess in Arterial blood by calculation
15
68
2.46
2.27
9.1
6.2
mmol/l
1.5
1.8
—
9
54
(40760892) CBC W Ordered Manual Differential panel - Blood
20
107
2.14
2.08
4.6
4.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
26
154
1.99
2.08
5.5
3.6
ph
7.4
7.4
—
5
25
(3000494) Fungus identified in Specimen by Culture
14
65
2.38
2.01
1.3
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
11
4.75
1.97
1.4
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
23
136
1.95
1.83
1.4
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
8
30
2.84
1.77
8.5
7.3
mmol/l
24.9
25.1
—
8
30
(3000850) Epithelial cells [#/volume] in Urine
21
122
1.96
1.75
2.0
2.0
e6/l
9.3
5.1
0.41
16
108
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
11
49
2.43
1.72
1.7
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
14
3.72
1.64
2.2
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
19
109
1.96
1.64
1.8
2.4
mosm/kgh2o
428.2
560.4
1.79
14
88
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
15
3.47
1.54
1.2
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
52
2.28
1.52
1.6
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
20
120
1.87
1.51
10.8
5.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
7
29
2.54
1.42
3.4
2.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
17
3.06
1.38
1.0
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
69
596
1.84
1.36
25.6
12.5
mg/l
32.0
24.9
1.16
59
453
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
10
48
2.23
1.34
1.6
1.7
u/l
28.2
29.6
—
10
37
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
29
203
1.65
1.29
2.6
2.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
26
179
1.65
1.23
2.7
2.7
e6/l
110.3
389.7
0.34
19
135
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
50
590
0.63
1.22
5.2
6.3
mmol/mol
39.6
41.5
0.96
43
543
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
20
2.59
1.17
1.6
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
7
30
2.45
1.15
1.4
1.8
g/l
10.8
9.1
—
7
25
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
53
614
0.64
1.14
4.7
5.4
mmol/l
2.7
2.6
0.42
47
558
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
75
1.87
1.10
6.0
8.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
9
47
2.02
1.06
8.1
3.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
24
168
1.60
1.05
2.8
2.6
e6/l
1.3
0.3
0.52
18
121
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
51
423
1.51
1.04
5.1
3.7
pmol/l
14.0
15.1
1.69
45
373
(40761535) Cells panel - Urine sediment
10
54
1.97
1.01
2.8
3.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
23
161
1.59
1.01
2.7
2.5
—
—
—
0
0
(3019225) pH of Specimen
10
55
1.93
0.97
2.9
2.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
15
223
0.60
0.96
4.3
4.2
mg/mmol
10.8
12.2
—
9
138
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
37
1.97
0.96
2.7
2.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
7
37
1.97
0.96
4.7
3.5
mmol/l
1.3
1.2
—
7
32
(3012544) pH of Venous blood
11
63
1.86
0.95
2.0
3.9
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
6
28
2.23
0.93
1.2
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
27
200
1.51
0.92
2.9
3.2
e6/l
240.3
67.7
0.48
20
144
(3026008) Bacteria identified in Urine by Culture
20
140
1.56
0.87
3.9
2.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
11
65
1.80
0.87
1.0
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
45
1.86
0.87
1.0
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
8
45
1.86
0.87
1.0
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
31
2.00
0.86
1.2
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
8
48
1.73
0.81
9.0
8.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
6
34
1.82
0.78
2.7
5.0
mmol/l
25.0
25.2
—
6
27
(3049717) Cytology report of Urine Cyto stain
5
23
2.24
0.77
1.8
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
23
2.24
0.77
1.6
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
38
1.92
0.76
1.7
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
69
628
1.52
0.75
23.2
12.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
53
594
0.71
0.72
3.9
4.8
mmol/l
1.5
1.4
0.68
46
540
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
26
1.98
0.72
1.0
1.0
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
7
42
1.73
0.70
2.3
2.4
g/l
120.7
126.3
—
7
42
(3044889) 12 lead EKG panel
52
453
1.38
0.69
4.9
4.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
27
1.90
0.69
1.2
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
7
43
1.68
0.68
1.0
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
16
217
0.68
0.66
2.6
3.3
mmol/l
6.6
7.6
0.71
16
182
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
54
599
0.73
0.64
4.3
4.8
mmol/l
4.7
4.5
0.58
48
547
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
36
299
1.35
0.64
2.4
2.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
5
30
1.71
0.62
10.6
8.2
mmol/l
25.6
25.6
—
5
25
(3021589) Normoblasts [#/volume] in Blood
30
243
1.36
0.62
10.4
8.6
e9/l
0.0
0.0
0.00
25
200
(3039443) Prostate specific Ag panel - Serum or Plasma
0
20
0.00
0.61
0.0
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
12
81
1.56
0.61
1.3
1.2
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
6
38
1.62
0.55
10.5
8.1
%
0.6
0.8
—
6
38
(3014007) Fractional oxyhemoglobin in Arterial blood
6
38
1.62
0.55
10.5
8.2
%
95.1
92.0
—
6
38
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
6
39
1.58
0.54
10.5
8.1
%
1.6
1.7
—
6
39
(3002032) Base excess in Venous blood by calculation
9
64
1.45
0.53
2.2
3.8
mmol/l
1.8
2.3
—
9
51
(3012516) Albumin [Mass/volume] in Urine
16
209
0.71
0.53
2.8
3.5
mg/l
38.1
373.7
—
10
139
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
13
93
1.47
0.52
2.3
2.9
e6/l
0.9
0.7
—
8
50
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
14
102
1.45
0.51
2.3
2.5
e6/l
1.2
0.9
—
9
59
(3020564) Creatinine [Moles/volume] in Serum or Plasma
69
643
1.39
0.50
30.7
15.3
umol/l
83.2
85.8
0.15
69
643
(3009542) Hematocrit [Volume Fraction] of Blood
58
529
1.30
0.48
24.0
13.0
%
39.0
40.7
0.61
37
365
(1761868) Lipid panel - Serum or Plasma
15
193
0.73
0.45
2.5
3.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
70
1.49
0.44
1.2
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
44
392
1.25
0.42
5.5
3.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
16
127
1.32
0.37
3.1
3.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
24
281
0.80
0.36
4.5
3.6
%
25.5
24.4
0.13
15
121
(3022621) pH of Urine by Test strip
6
44
1.39
0.35
2.8
2.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
6
46
1.33
0.34
9.5
2.8
e9/l
4.4
3.3
—
6
33
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
31
273
1.21
0.31
3.7
3.9
ng/l
23.8
44.0
1.51
26
198
(3002385) Erythrocyte distribution width [Ratio]
52
482
1.20
0.30
28.4
14.2
%
14.0
13.6
1.81
52
470
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
56
1.27
0.30
5.4
2.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
7
56
1.27
0.30
3.7
3.5
ng/l
473.0
170.0
—
7
49
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
21
242
0.82
0.27
2.2
2.0
pmol/l
100.4
91.2
0.46
12
120
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
10
0.00
0.21
0.0
1.6
—
104.7
—
0
10
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
10
0.00
0.21
0.0
1.6
—
4.2
—
0
10
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
57
542
1.16
0.20
6.6
4.4
mu/l
3.4
2.0
2.28
51
481
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
55
577
0.87
0.20
3.4
4.3
mmol/l
1.3
1.3
0.08
48
523
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
18
200
0.87
0.14
3.0
2.5
ug/l
0.8
0.8
0.01
13
125
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
57
590
0.90
0.13
4.4
4.7
mmol/l
5.8
6.2
1.79
52
526
(3013512) EKG study
21
192
1.12
0.12
3.5
3.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
5
44
1.14
0.10
4.8
3.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
66
644
1.11
0.10
15.0
8.9
u/l
23.2
25.9
0.81
66
612
(3041096) Erythrocytes [Presence] in Urine by Automated
14
154
0.89
0.09
4.8
2.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
6
58
1.04
0.08
1.3
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
26
270
0.95
0.04
7.4
4.4
estimate
0.0
0.0
—
5
51
(3035350) Ketones [Presence] in Urine by Test strip
26
270
0.95
0.04
4.8
3.4
estimate
0.0
0.0
—
5
50
(3009261) Glucose [Presence] in Urine by Test strip
27
278
0.96
0.02
4.3
3.4
estimate
0.0
0.0
—
5
51
(3015736) pH of Urine
21
204
1.04
0.00
4.4
3.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
56
566
0.97
0.00
24.9
11.5
ml/min/173m2
81.5
76.4
0.83
50
462
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4062490)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000492) Spirometry study
6
60
1.00
0.00
1.2
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
8
0.00
0.00
0.0
4.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4306422)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
468.0
—
0
5
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
22
220
1.00
0.00
6.5
3.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_LIP_ORAL_PHARYNX_NAS_EXALLC – Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).